News
Important Only
Home Depot sees fiscal 2026 sales, profit below estimates ahead of investor day
Dec 9 (Reuters) - Home improvement chain Home Depot HD.N on Tuesday forecast fiscal 2026 comparable sales growth and profit below analysts' estimates as demand for do-it-yourself projects and big-ticket items cools.Shares of the company were down 1.6% in premarket trading after the retailer outl...Reuters
Tue, Dec 9
CoreWeave down after it hikes convertible notes offering to $2.25 billion
Shares of cloud infrastructure firm CoreWeave CRWV.O, backed by NvidiaNVDA.O, down 1.7% at $84.80 premarket CRWV prices 1.75% convertible senior notes at $2.25 bln, up from initially planned $2 blnNotes due 2031, settlement scheduled Dec 11, 2025, subject to closing conditions - CRWVUp to last close...Reuters
Tue, Dec 9
LIVE MARKETS-Getting thin for the holidays
STOXX 600 down 0.1%Eyes on Fed this weekNasdaq futures steadyWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com GETTING THIN FOR THE HOLIDAYSIf it's feeling thin out there in te...Reuters
Tue, Dec 9
SPAC ATMC soars after shareholder approval of HCYC merger
Shares of special purpose acquisition company AlphaTime Acquisition Corp ATMC.O rise 604% to $109 in premarket tradingATMC shareholders approve merger with intermediary insurance brokerage company HCYC holdings CoSPACs are publicly listed shell companies that raise funds with the intention of mergin...Reuters
Tue, Dec 9
TotalEnergies cements Namibia position with Galp asset swap
Total to get 40% in PEL83 licence holding the Mopane projectGalp to get 10% interest in PEL56 licence and 9.4% in PEL91Total, Galp plan to drill 3 wells in Mopane in 2 years from 2026Total shares edge higher, Galp stock slumpsBy Alban Kacher, Shadia Nasralla and Sergio Goncalves Dec 9 (Reuters) -...Reuters
Tue, Dec 9
CVS climbs after raising 2025 profit forecast
Shares of health insurer CVS Health CVS.N rise 3.3% to $79.01 premarketCVS raises 2025 adjusted profit forecast to $6.60 to $6.70 per share from previous outlook of $6.55 to $6.65 Co forecasts 2026 adjusted profit in the range of $7.00 to $7.20 per share vs analysts' average estimate of $7.16 - ...Reuters
Tue, Dec 9
Core & Main gains after upbeat quarterly profit, share buyback hike
Shares of water pipe distributor Core & Main CNM.N surge nearly 7.6% to about $54.4 premarket CNM beats Q3 profit estimates, driven by acquisitions and strong sales initiatives, despite soft residential demand Q3 adj. EPS of 89 cents, above analysts' estimate of 78 cents Q3 sales...Reuters
Tue, Dec 9
LIVE MARKETS-Reasons to be bullish about European defence next year
STOXX 600 down 0.1%Eyes on Fed this weekNasdaq futures steadyWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com REASONS TO BE BULLISH ABOUT EUROPEAN DEFENCE NEXT YEARMorgan Stanley ...Reuters
Tue, Dec 9
Vor Bio jumps as J.P.Morgan initiates with 'overweight' rating
Shares of Vor Biopharma VOR.O rise 67% to $13.97 premarketJ.P.Morgan starts coverage with "overweight" rating and PT of $43, which represents 414% upside to the stock's last closeBrokerage says VOR's autoimmune disease drug, telitacicept, licensed from China's RemeGen 688331.SS, ...Reuters
Tue, Dec 9
FTSE 100 edges up as defence stocks offset BAT losses
FTSE 100 up 0.1%, FTSE 250 up 0.2%BAT sees 2026 growth at lower end of targetUK consumer spending in November disappointsThe UK's blue-chip FTSE 100 edged higher on Tuesday, as gains in defence stocks helped offset a slide in shares of British American Tobacco following a downbeat growth forecas...Reuters
Tue, Dec 9
Pfizer partners with China's YaoPharma for weight loss drug; shares up
Shares of vaccine maker Pfizer PFE.N rise 1.5% to $26.15 premarketPfizer says it has entered into an exclusive licensing agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical 600196.SS, for the development and commercialization of an experimental weight management treatmentYaoPharm...Reuters
Tue, Dec 9
MORNING BID AMERICAS-Wobbling bonds find a level as Fed meets
By Mike Dolan Dec 9 - What matters in U.S. and global markets todayBy Mike Dolan, Editor-At-Large, Finance and MarketsFed week got off to a rocky start in global markets, courtesy of bond market hits across the world, but government debt yields stabilized on Tuesday as the Federal Reserve started...Reuters
Tue, Dec 9
Toll Brothers falls after Q4 profit miss
Homebuilder Toll Brothers' TOL.N shares fall 3.8% premarket to $131Co reports Q4 adj. EPS of $4.58, lower than analysts' average estimate of $4.89, according to LSEG dataTOL's Q4 net signed contract value stood at $9.85 bln vs $10.07 bln in previous year; contracted homes were 9,943 vs 1...Reuters
Tue, Dec 9
US STOCKS-Wall St futures flat as Fed decision looms, Nvidia gains
Futures up: Dow 0.06%, S&P 500 0.09%, Nasdaq 0.09% Dec 9 (Reuters) - U.S. stock index futures were flat on Tuesday as investors remained cautious a day ahead of a long-anticipated monetary policy decision by the Federal Reserve, while Nvidia gained after the chip giant received approval t...Reuters
Tue, Dec 9
Home Depot Stock Falls After Giving Cautious Preliminary Forecast for Next Year
Home Depot Inc. is offering cautious preliminary guidance for next year, a sign that the home-improvement retailer doesn’t anticipate the housing market to rebound in the short term.Home Depot shares edged down 1.4% in premarket trading Tuesday.The company expects comparable sales growth to be in a ...Tiger News
Tue, Dec 9
Ford to use Renault tech, plants to battle cheap Chinese EVs in Europe
Smaller European EVs fill a gap in Ford's lineupPartnership formed after Renault team visited Ford in DetroitFord's share of European passenger car markets has shrunkBy Nick Carey and Gilles Guillaume PARIS, Dec 9 (Reuters) - Renault RENA.PA will jointly develop small, cheaper electric ve...Reuters
Tue, Dec 9
Street View: IBM powers up AI game with Confluent deal
IBM IBM.N said on Monday it will buy data infrastructure company Confluent CFLT.O in a deal valued at $11 billion, ramping up its cloud-computing offerings to capitalize on an AI-driven demand boomIBM will use cash on hand to fund the Confluent deal, which is expected to close by mid-2026 WHEN O...Reuters
Tue, Dec 9
CANADA STOCKS-TSX futures steady ahead of expected Fed rate cut
Dec 9 (Reuters) - Futures for Canada's main stock index were little changed on Tuesday, supported by higher precious metal prices, as investors remained cautious ahead of the outcome of the two-day U.S. Federal Reserve policy meeting tomorrow.Futures on the S&P/TSX Composite Index SCFcv1 wer...Reuters
Tue, Dec 9
